Considerations for the safe prescribing and use of COX-2-specific inhibitors

DR Barraclough, JV Bertouch, P Brooks, MA Brown, LG Cleland, LE Clemens, SJ Crowley, RO Day, JP DeJager, JP Edmonds, PJ Fletcher, GR Franks, DC Harris, JD Horowitz, MD Johnston, SJ Kerr, GO Littlejohn, GJ MacDonald, GJ McColl, PN Sambrook Show all